MedTrace Logo

Evaluate the Depth and Duration of Anesthesia

NCT00891163 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2009-05-01

No results posted yet for this study

Summary

The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory testing evaluations), compared with a matching heated placebo patch.

Conditions

Interventions

DRUG

Synera™ Topical Patch (70 mg lidocaine/70 mg tetracaine)

30 minute applicable on antecubital fossa

DRUG

Placebo Patch

placebo

Sponsors & Collaborators

  • Endo Pharmaceuticals

    collaborator INDUSTRY

  • ZARS Pharma Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00891163 on ClinicalTrials.gov